Article
GLCCI1 single nucleotide polymorphisms in pediatric nephrotic syndrome.
Pediatric nephrology (Berlin, Germany) - 1 Sept 2012
Cheong Hae Il, Kang Hee Gyung, Schlondorff Johannes
Abstract excerpt
BACKGROUND: Empiric steroid therapy is the first-line therapy for pediatric nephrotic syndrome, but treatment response is variable. There are few predictors of steroid-responsiveness, although evidence for genetic factors does exist. Single nucleotide polymorphisms (SNPs) have been recently identified in the promoter region of glucocorticoid-induced transcript 1 gene (GLCCI1) which affect steroid-responsiveness...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
